Independent Conference Coverage from the CHEST 2018 Annual Meeting*
Supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., and Actelion.

 

Take Home Messages from the 2018 CHEST Annual Meeting

Evolution of Antifibrotic Therapy in IPF

 

 


Overview of the Latest Clinical Trials in IPF

Updates in the Diagnosis of ILD and the Role of Cryobiopsy

 



Management of IPF Patients in 2018

Comparing the 2017 Fleischner Society Guidelines and the 2018 ATS Guidelines for Diagnosing IPF

 


What We’re Learning from the IPF-PRO Registry

The Importance of Early Integration of Palliative Care

 


Updates in Inoperable CTEPH

Download Audio


*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the 2018 CHEST Annual Meeting.
 

Access other Therapeutic Areas: